{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:36:48Z","timestamp":1773092208684,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Federal Ministry of Health","award":["FKZ: 2513AUK375"],"award-info":[{"award-number":["FKZ: 2513AUK375"]}]},{"name":"German Federal Ministry of Health","award":["FKZ: 2513AUK375"],"award-info":[{"award-number":["FKZ: 2513AUK375"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206234","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T23:09:26Z","timestamp":1541718566000},"page":"e0206234","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1598-0921","authenticated-orcid":true,"given":"Andrea","family":"Hauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-3482","authenticated-orcid":true,"given":"Alexandra","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolin","family":"Meixenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bartmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Bannert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"ref1","year":"2017"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1097\/QAD.0000000000000864","article-title":"HIV treatment cascades: how can all countries reach the UNAIDS 90-90-90 target?","volume":"29","author":"A Hill","year":"2015","journal-title":"AIDS"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"L Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref4","unstructured":"Deutsche AIDS-Gesellschaft (DAIG), \u00d6sterreichische AIDS-Gesellschaft (\u00d6AIG), Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), Deutsche STI-Gesellschaft (DSTIG), Deutsche Gesellschaft f\u00fcr Infektiologie (DGI), Gesellschaft f\u00fcr Virologie (GfV), et al. Deutsch-\u00d6sterreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. 2015. p. 50."},{"key":"ref5","unstructured":"European AIDS Clinical Society (EACS). Guidelines Version 9.0 October 2017. European Guidelines for treatment of HIV-infected adults in Europe2017."},{"key":"ref6","unstructured":"WHO. Towards universal access: Scaling up priority HIV\/AIDS interventions in the health sector Progress report 2010. 2010."},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.2.30436","article-title":"National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014","volume":"22","author":"A Hauser","year":"2017","journal-title":"Euro Surveill"},{"issue":"49","key":"ref8","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.49.17-00269","article-title":"Assessment of HIV molecular surveillance capacity in the European Union, 2016","volume":"22","author":"P Keating","year":"2017","journal-title":"Euro Surveill"},{"key":"ref9","unstructured":"WHO. WHO HIV drug resistance laboratory strategy. 2010."},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"D Bennett","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"SY Rhee","year":"2015","journal-title":"PLoS Med"},{"key":"ref12","first-page":"26620652","article-title":"Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe","author":"LM Hofstra","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(11)70248-1","article-title":"Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study","volume":"12","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1128\/JVI.02579-07","article-title":"Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection","volume":"82","author":"SJ Little","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"e1004722","DOI":"10.1371\/journal.ppat.1004722","article-title":"Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds","volume":"11","author":"WL Yang","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1128\/JVI.72.5.3520-3523.1998","article-title":"Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants","volume":"72","author":"S Yerly","year":"1998","journal-title":"J Virol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jac\/dkw071","article-title":"Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors","volume":"71","author":"BG Brenner","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref18","unstructured":"Clinical EA, EACS S. EACS Treatment Guidelines updated: Version 7.1\u2014November 2014 2014."},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12879-017-2585-4","article-title":"Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014","volume":"17","author":"A Hofmann","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12985-017-0887-1","article-title":"Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors","volume":"14","author":"K Meixenberger","year":"2017","journal-title":"Virol J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jviromet.2018.05.013","article-title":"Robust and sensitive subtype-generic HIV-1 pol genotyping for use with dried serum spots in epidemiological studies","volume":"259","author":"A Hauser","year":"2018","journal-title":"J Virol Methods"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"e0178297","DOI":"10.1371\/journal.pone.0178297","article-title":"Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT","volume":"12","author":"P Machnowska","year":"2017","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"AC Pineda-Pena","year":"2013","journal-title":"Infect Genet Evol"},{"issue":"18","key":"ref24","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1093\/nar\/gku739","article-title":"COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification","volume":"42","author":"D Struck","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"TF Liu","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"LT Nguyen","year":"2015","journal-title":"Mol Biol Evol"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/molbev\/mst024","article-title":"Ultrafast approximation for phylogenetic bootstrap","volume":"30","author":"BQ Minh","year":"2013","journal-title":"Mol Biol Evol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/QAI.0000000000001122","article-title":"Inferring HIV-1 Transmission Dynamics in Germany From Recently Transmitted Viruses","volume":"73","author":"K Pouran Yousef","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/jiv758","article-title":"Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters","volume":"213","author":"M Ragonnet-Cronin","year":"2016","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2105-14-317","article-title":"Automated analysis of phylogenetic clusters","volume":"14","author":"M Ragonnet-Cronin","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"W13","DOI":"10.1097\/01.aids.0000247564.73009.bc","article-title":"Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004","volume":"20","author":"J Hemelaar","year":"2006","journal-title":"AIDS"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"vew010","DOI":"10.1093\/ve\/vew010","article-title":"HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries","volume":"2","author":"J Esbjornsson","year":"2016","journal-title":"Virus Evol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.meegid.2016.06.033","article-title":"Molecular epidemiology of HIV-1 infection in Europe: An overview","volume":"46","author":"A Beloukas","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"e99390","DOI":"10.1371\/journal.pone.0099390","article-title":"Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades","volume":"9","author":"U Neogi","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"e95956","DOI":"10.1371\/journal.pone.0095956","article-title":"First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study","volume":"9","author":"F Zu Knyphausen","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/hiv.12414","article-title":"Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom","volume":"18","author":"A Tostevin","year":"2017","journal-title":"HIV Med"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/jac\/dkx231","article-title":"Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000\u201314","volume":"72","author":"L Fabeni","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"ref38","article-title":"Klinische Aspekte der HIV-Versorgung Die ClinSurv-HIV-Kohorte Epidemiologisches Bulletin","volume":"28","author":"RK Institute","year":"2016"},{"key":"ref39","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","author":"RK Gupta","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.meegid.2017.07.003","article-title":"Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003\u20132015: Transmitted drug resistance is due to onward transmissions","volume":"54","author":"D Paraskevis","year":"2017","journal-title":"Infect Genet Evol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000000831","article-title":"Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996\u20132013","volume":"71","author":"T Panichsillapakit","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cit694","article-title":"Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study","volume":"58","author":"SM Drescher","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/civ393","article-title":"Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom","volume":"61","author":"JL Mbisa","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","DOI":"10.3390\/genes8110322","article-title":"Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naive Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health","volume":"8","author":"D Paraskevis","year":"2017","journal-title":"Genes (Basel)"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"e0172473","DOI":"10.1371\/journal.pone.0172473","article-title":"Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland","volume":"12","author":"M Parczewski","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/jac\/dkv049","article-title":"HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007\u201312: impact on susceptibility to first-line strategies","volume":"70","author":"P Frange","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15284336.2016.1153303","article-title":"Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients","volume":"17","author":"M Sayan","year":"2016","journal-title":"HIV Clin Trials"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T23:05:56Z","timestamp":1605395156000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206234"}},"subtitle":[],"editor":[{"given":"Chiyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206234","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]}}}